Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.68 |
| ▸ | TGM2 | P21980 | 1/20 | 0.68 |
| ▸ | KRAS | P01116 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.63 |
| ▸ | HINT1 | P49773 | 1/20 | 0.60 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.59 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.59 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.59 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.58 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.57 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.57 |
| ▸ | GSK3A | P49840 | 2/20 | 0.57 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.57 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanosine SCHEMBL19211836 | 1.00 | NT5E (0.68) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL4625995 | 1.00 | NT5E (0.68) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL30589987 | 0.99 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL9827513 | 0.99 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL6066347 | 0.99 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL37404 | 0.96 | NT5E (0.70) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL27797461 | 0.96 | NT5E (0.70) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL4410882 | 0.95 | TGM2 (0.65) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL22134208 | 0.95 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL29046528 | 0.95 | TGM2 (0.64) | NT5ETGM2KRASHPGDFUT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209037-A1 | MUTANT SPOT PROTEIN AND METHOD FOR PRODUCING L-AMINO ACIDS USING SAME | CJ CHEILJEDANG CORPORATION (KR) | 2024-06-27 | — | — | US | disclosed |
| EP-4306536-A1 | MUTANT SPOT PROTEIN AND METHOD FOR PRODUCING L-AMINO ACIDS USING SAME | CJ Cheiljedang Corporation (KR) | 2024-01-17 | — | — | EP | disclosed |
| US-11549096-B2 | Genetic perturbation of the RNA degradosome protein complex | ZYMERGEN INC. (US) | 2023-01-10 | — | — | US | disclosed |